![]() |
Establishing Acceptance Limits for Dissolution Performance Verification of USP Apparatus 1 and 2 Using USP Prednisone Tablets Reference Standard Lot Q0H398
Walter W. Hauck, Chensheng Li, Erika S. Stippler, and William E. Brown
PhEq_bootstrap:Open-Source Software for the Simulation of f2Distribution in Cases of Large Variability in Dissolution Profiles
Aleksander Mendyk, Adam Pacławski, Jakub Szlęk, and Renata Jachowicz
Discriminatory Dissolution Test for Tablets Containing α- and β-Thalidomide Polymorphs
Ana Paula Cappra Silva1, Leonardo Zanchetti Meneghini1,
Lisiane Bajerski1, Juliana Poglia Carini1,Silvia Ligório Fialho2, Paulo Mayorga1, and Pedro Eduardo Fröehlich1
In Vitro Release Evaluation of Gastroretentive Amoxicillin Floating Tablets Employing a Specific Design of the Flow-Through Cell
Laila H. Emara1, Aya R. Abdou1, Ahmed A. El-Ashmawy1,Rania M. Badr1, Nesrin F. Taha1, and Nadia M. Mursi2
Physicochemical Characterization and Dissolution Study of Ibuprofen Compression-Coated Tablets Using Locust Bean Gum
Negar Bashardoust1,2, J. Josephine Leno Jenita1, and Parvin Zakeri-Milani3
UV Analytical Method Suitability for Investigation of BCS Class 2 Biowaivers: Ibuprofen Case
Noelia L. Gonzalez Vidal1 and M. Esther Gil Alegre2
Comparison of In Vitro Dissolution Tests for Commercially Available Aspirin Tablets
Fawzia Khan, Mingzhong Li, and Walkiria Schlindwein
Tribute to Dirk BarendsQuestion & Answer Section
Margareth Marques and William Brown
|
![]() |
Dissolution Testing of a Controlled-Release Capsule Formulation: Challenges and Solutions Using a Semi-Automated Dissolution System
Lili Lo, Xujin Lu, and David Lloyd
In Situ Drug Release Monitoring with a Fiber-Optic System: Overcoming Matrix Interferences Using Derivative Spectrophotometry
Alexis Guillot1,2, Markus Limberger1, Johannes Krämer1, and Claus-Michael Lehr2
Effect of a Fiber-Optic Probe on the Dissolution of Salicylic Acid Tablets in USP Apparatus 2
Bing Wang1, Gerard Bredael2, and Piero M. Armenante1
Evaluation of Automation to Increase Efficiency in the Dissolution Lab
Jonathan Kretz and Kirby Wong-Moon
A Primer on Automating the Vertical Diffusion Cell (VDC)
Royal Hanson and John Heaney
Considerations for Automating the Dissolution Test
G. Bryan Crist
Survey Results for In Vitro-In Vivo Correlations (IVIVC): Critical Variables for Success
Nikoletta Fotaki1, Vivian Gray2, Filippos Kesisoglou3, Steve Mayock4, Tahseen Mirza5, Alger Salt6, and Arzu Selen7
Meeting Report: AAPS Workshop on Oral Bioperformance and 21st Century Testing
Margareth Marques
Dissolution Highlights from the 2012 AAPS Annual Meeting in Chicago
Nikoletta Fotaki1, Gregory P. Martin2, and Johannes Krämer3
Question & Answer Section
Margareth Marques and William Brown
|
![]() |
Rationale for Selection of Dissolution Media: Three Case Studies
Nikoletta Fotaki1, William Brown2, Jianmei Kochling3, Hitesh Chokshi4, Hai Miao5, Kin Tang4, and Vivian Gray6
Enhancement in Dissolution Rate of Piroxicam by Two Micronization Techniques
J. Varshosaz, A. Khajavinia, M. Ghasemlu, E. Ataei, K. Golshiri, and I. Khayam
A Dissolution Test for Finasteride in Immediate-Release Capsules
Olimpia Maria Martins Santos, Ana Laura Araújo Santos, Gislaine Ribeiro Pereira,
Rudy Bonfilio, and Magali Benjamim de Araújo
The Effect of Probe Path Length Calibration on Dissolution Tests Performed with a Fiber-Optic In Situ Dissolution Test System
Pingping Xu, Xinxia Li, Li Li, Yang Liu, Bin Kong, Kun Nie, and Jian Chen
Comparison of the Solubility and Dissolution of Drugs in Fasted-State Biorelevant Media (FaSSIF and FaSSIF-V2)
Mathew Leigh, Bastian Kloefer, and Michael Schaich
Meeting Report: AAPS Workshop on Dissolution Testing and Bioequivalence
Vivian A. Gray
Updates on USP Activities Related to Dissolution, Disintegration, and Drug Release
Margareth R. C. Marques and William Brown
Question & Answer Section
Margareth Marques and William Brown
|
![]() |
Investigation of the Disintegration Behavior of Dietary Supplements in Different Beverages
Jieyu Zuo, Yuan Gao, May Almukainzi, and Raimar Löbenberg
In Vitro Dissolution of Insulin Crystal Polymorphs at Model Conditions Relevant to In Vivo Environment
I. Dimitrov1, F. Hodzhaoglu1, and I. Ivanov2
Development and Validation of a Discriminating Dissolution Method for Darifenacin Extended-Release Tablets
Leonardo Z. Meneghini1, Vinícius Bicca1,2, César A. Junqueira1, Andréa I. H. Adams2, Graciela Carlos1, Pedro E. Fröehlich1, and Ana M. Bergold1
Comparative Dissolution Studies of Albendazole Oral Suspensions for Veterinary Use
Noelia L. Gonzalez Vidal11, Walter J. Starkloff1, Silvia Bentancor2, Silvina Castro3, Gonzalo Suarez2, and Santiago D. Palma3
Remembering Jim Swon, Industry PioneerIn Vitro Dissolution Enhancement of Ondansetron by Solid Dispersion in Superdisintegrants
Rajnikant M. Suthar1, Narendra P. Chotai1, Hardik K. Patel1, Sandip R. Patel1, Digesh D. Shah2, and Mukesh B. Jadeja3
Technical Note: Non-Sink Dissolution Media for Identification of Functional Formulation Excipients— The Case of a Precipitation Inhibitor
Maria T. Cruañes, Kimberly Bentz, Wei Xu, and Laura Artino
CRS Workshop Report: Using an In Vitro-In Vivo Correlation (IVIVC) to Meet Challenges in Global Delivery
Mario A. Gonzalez1 and Vivian A. Gray2
AAPS Workshop Report on Biorelevant In Vitro Performance Testing of Orally Administered Dosage Forms
Johannes Krämer
Approaches to the Investigation of Dissolution Testing Changes and Failures: AAPS Webinar Summary
Jianmei Kochling
Question & Answer Section
Margareth Marques and William Brown
|